The acquisition is carried out through Episurf’s purchase of all shares in XX22 AB and its wholly owned subsidiary Mofast Invest II AB, as well as indirect subsidiaries from Mofast AB. This transaction further strengthens the company’s real estate investment initiative by adding a diversified portfolio of social infrastructure properties with stable rental income.

“This acquisition from Mofast represents an important step for us. It contributes stable cash flows and increases the scale of our platform, thereby creating the conditions for genuine scalability and strong returns. At the same time, we are strengthening our ownership base with established investors and expanding our collaboration with Nordic banks,” says Jens Andersson, CEO of Episurf Medical.

“The divestment is beneficial for Mofast. We also believe that the price once again demonstrates our ability to dispose of properties in line with net asset value. At the same time, we have confidence in Ilija Batljan’s and Jens Andersson’s ability to build strong shareholder value in Episurf,” says Eric Fischbein, CEO of Mofast.